Bnp Paribas Arbitrage, Snc »

Evommune shares owned by Bnp Paribas Arbitrage, Snc

Quarter-by-quarter ownership of Evommune (EVMN) shares owned by Bnp Paribas Arbitrage, Snc from 13F filings

Historical chart of Bnp Paribas Arbitrage, Snc investment in Evommune

Tip: Access up to 7 years of quarterly data

All positions including Evommune held by Bnp Paribas Arbitrage, Snc consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Evommune by Bnp Paribas Arbitrage, Snc

Quarter filed Position value Share count Share price at filing
2026-03-31 $51k 2.2k 22.99

More positions owned by Bnp Paribas Arbitrage, Snc

NVIDIA Corp Equity (NVDA)
Microsoft Corp Equity (MSFT)
Amazon.com Equity (AMZN)
Apple Equity (AAPL)
State Street SPDR S&P Biotech ETF Fund (XBI)
Tesla Equity (TSLA)
Broadcom Equity (AVGO)
Alphabet Equity (GOOGL)
Alphabet Equity (GOOG)
JPMorgan Chase & Co Equity (JPM)
Meta Platforms Equity (META)
State Street SPDR S&P 500 ETF Trust Fund (SPY)
Micron Technology Equity (MU)
iShares Russell 2000 ETF Fund (IWM)
Oracle Corp Equity (ORCL)

View all positions for Bnp Paribas Arbitrage, Snc

Top funds holding Evommune

EQT Fund Management S.a r.l.
RA Capital Management
Pivotal bioVenture Partners Investment Advisor
Andera Partners
MPM Oncology Impact Management
Nan Fung Group Holdings
Rtw Investments
SymBiosis Capital Partners
Marshall Wace
Eventide Asset Management
Henderson Group
Baker Bros. Advisors
Alyeska Investment Group
BlackRock
Kynam Capital Management

View all funds holding Evommune